Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.

Cotiviti, which is backed by KKR and Veritas Capital, has agreed to acquire Edifecs, a Bellevue, Washington-based healthcare data firm. No financial terms were disclosed. Francisco Partners and TA ...

Cotiviti, a leader in data-driven healthcare solutions, announces an agreement to acquire Edifecs, a pioneer in healthcare ...

if the acquisition of Edifecs goes ahead, the people said, who asked not to be named discussing ...

$540 $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available until 27 February 2025. Then $75 per month. Complete digital access to ...

Evercore ISI analyst Glenn Schorr maintained a Buy rating on KKR & Co (KKR – Research Report) yesterday and set a price target of $165.00.

Citi analyst Christopher Allen reiterated a Buy rating on KKR & Co (KKR – Research Report) today. The company’s shares closed yesterday at $149.30. Leverage the power of TipRanks' Smart Score ...